33433498|t|Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model.
33433498|a|Patients with Parkinson's disease (PD) have impaired insulin signaling in the brain. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), can re-sensitize insulin signaling. In a recent phase II clinical trial, the first GLP-1 mimic, exendin-4, has shown reliable curative effect in patients with PD. DA-CH5 is a novel GLP-1/GIP receptor unimolecular co-agonist with a novel peptide sequence added to cross the blood-brain barrier. Here we showed that both exendin-4 and DA-CH5 protected against 6-hydroxydopamine (6-OHDA) cytotoxicity, inhibited apoptosis, improved mitogenesis and induced autophagy flux in SH-SY5Y cells via activation of the insulin receptor substrate-1 (IRS-1)/alpha serine/threonine-protein kinase (Akt)/cAMP response element-binding protein (CREB) pathway. We also found that DA-CH5 (10 nmol/kg) daily intraperitoneal administration for 30 days post-lesion alleviated motor dysfunction in rats and prevented stereotactic unilateral administration of 6-OHDA induced dopaminergic neurons loss in the substantia nigra pars compacta. However, DA-CH5 showed curative effects in reducing the levels of alpha-synuclein and the levels of pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta). It was also more effective than exendin-4 in inhibiting apoptotic process and protecting mitochondrial functions. In addition, insulin resistance was largely alleviated and the expression of autophagy-related proteins was up-regulated in PD model rats after DA-CH5 treatment. These results in this study indicate DA-CH5 plays a therapeutic role in the 6-OHDA-unilaterally lesioned PD rat model and is superior to GLP-1 analogue exendin-4. The study was approved by the Animal Ethics Committee of Shanxi Medical University of China.
33433498	0	23	Glucagon-like peptide-1	Gene	24952
33433498	24	68	glucose-dependent insulinotropic polypeptide	Gene	25040
33433498	91	97	DA-CH5	Chemical	-
33433498	113	122	exendin-4	Chemical	MESH:D000077270
33433498	152	169	6-hydroxydopamine	Chemical	MESH:D016627
33433498	170	173	rat	Species	10116
33433498	174	183	Parkinson	Disease	MESH:D010302
33433498	191	199	Patients	Species	9606
33433498	205	224	Parkinson's disease	Disease	MESH:D010300
33433498	226	228	PD	Disease	MESH:D010300
33433498	244	251	insulin	Gene	3630
33433498	305	328	glucagon-like peptide-1	Gene	2641
33433498	330	335	GLP-1	Gene	2641
33433498	341	385	glucose-dependent insulinotropic polypeptide	Gene	2695
33433498	387	390	GIP	Gene	2695
33433498	410	417	insulin	Gene	3630
33433498	476	481	GLP-1	Gene	2641
33433498	489	498	exendin-4	Chemical	MESH:D000077270
33433498	538	546	patients	Species	9606
33433498	552	554	PD	Disease	MESH:D010300
33433498	556	562	DA-CH5	Chemical	-
33433498	574	579	GLP-1	Gene	24952
33433498	712	721	exendin-4	Chemical	MESH:D000077270
33433498	726	732	DA-CH5	Chemical	-
33433498	751	768	6-hydroxydopamine	Chemical	MESH:D016627
33433498	770	776	6-OHDA	Chemical	MESH:D016627
33433498	778	790	cytotoxicity	Disease	MESH:D064420
33433498	864	871	SH-SY5Y	CellLine	CVCL:0019
33433498	900	928	insulin receptor substrate-1	Gene	3667
33433498	930	935	IRS-1	Gene	3667
33433498	976	979	Akt	Gene	207
33433498	1020	1024	CREB	Gene	1385
33433498	1054	1060	DA-CH5	Chemical	-
33433498	1146	1163	motor dysfunction	Disease	MESH:D000068079
33433498	1167	1171	rats	Species	10116
33433498	1228	1234	6-OHDA	Chemical	MESH:D016627
33433498	1317	1323	DA-CH5	Chemical	-
33433498	1374	1389	alpha-synuclein	Gene	29219
33433498	1412	1424	inflammatory	Disease	MESH:D007249
33433498	1436	1463	tumor necrosis factor-alpha	Gene	24835
33433498	1465	1482	interleukin-1beta	Gene	24494
33433498	1517	1526	exendin-4	Chemical	MESH:D000077270
33433498	1612	1630	insulin resistance	Disease	MESH:D007333
33433498	1723	1725	PD	Disease	MESH:D010300
33433498	1732	1736	rats	Species	10116
33433498	1743	1749	DA-CH5	Chemical	-
33433498	1798	1804	DA-CH5	Chemical	-
33433498	1837	1843	6-OHDA	Chemical	MESH:D016627
33433498	1866	1868	PD	Disease	MESH:D010300
33433498	1869	1872	rat	Species	10116
33433498	1898	1903	GLP-1	Gene	24952
33433498	1913	1922	exendin-4	Chemical	MESH:D000077270
33433498	Negative_Correlation	MESH:D000077270	MESH:D016627
33433498	Association	2641	3630
33433498	Positive_Correlation	MESH:D000077270	1385
33433498	Positive_Correlation	MESH:D000077270	3667
33433498	Negative_Correlation	MESH:D000077270	MESH:D010302
33433498	Association	2695	3630
33433498	Negative_Correlation	MESH:D000077270	MESH:D064420
33433498	Association	MESH:D010300	3630
33433498	Positive_Correlation	MESH:D000077270	207
33433498	Negative_Correlation	MESH:D000077270	MESH:D010300
33433498	Positive_Correlation	MESH:D000077270	25040

